--Activist hedge fund Bluebell Capital Partners has taken a small stake in GlaxoSmithKline PLC to push for Chief Executive Emma Walmsley to reapply for her job, the Financial Times reports.

--Bluebell said the pharma company should launch a "thorough and robust process" to find a leader as Ms. Walmsley's time as CEO has resulted in lower shareholder returns than those of rivals, according to the FT.

 

Full story: https://on.ft.com/3kwC1sP

 

Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com

 

(END) Dow Jones Newswires

September 23, 2021 06:16 ET (10:16 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Gsk
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Gsk